Genetic Variants and Functional Pathways Associated with Resilience to Alzheimer’s Disease
Abstract Approximately 30% of older adults exhibit the neuropathologic features of Alzheimer’s disease (AD) without signs of cognitive impairment. Yet, little is known about the genetic factors that allow these potentially resilient individuals to remain cognitively normal in the face of substantial neuropathology. We performed a large, genome-wide association study (GWAS) of two previously validated metrics of cognitive resilience quantified using a latent variable modeling approach and representing better-than-predicted cognitive performance for a given level of neuropathology. Data were harmonized across 5,108 participants from a clinical trial of AD and three longitudinal cohort studies of cognitive aging. All analyses were run across all participants and repeated restricting the sample to individuals with normal cognition to identify variants at the earliest stages of disease. As expected, all resilience metrics were genetically correlated with cognitive performance and education attainment traits (p-values<2.5×10−20), and we observed novel correlations with neuropsychiatric conditions (p-values<7.9×10−4). Notably, neither resilience metric was genetically correlated with clinical AD (p-values>0.42) nor associated withAPOE(p-values>0.13). In single variant analyses, we observed a genome-wide significant locus among participants with normal cognition on chromosome 18 upstream ofATP8B1(index SNP rs2571244, MAF=0.08, p=2.3×10−8). The top variant at this locus (rs2571244) was significantly associated with methylation in prefrontal cortex tissue at multiple CpG sites, including one just upstream ofATPB81(cg19596477; p=2×10−13). Overall, this comprehensive genetic analysis of resilience implicates a putative role of vascular risk, metabolism, and mental health in protection from the cognitive consequences of neuropathology, while also providing evidence for a novel resilience gene along the bile acid metabolism pathway.Furthermore, the genetic architecture of resilience appears to be distinct from that of clinical AD, suggesting that a shift in focus to molecular contributors to resilience may identify novel pathways for therapeutic targets..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
bioRxiv.org - (2022) vom: 16. Okt. Zur Gesamtaufnahme - year:2022 |
|---|
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| doi: |
10.1101/2020.02.19.954651 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI017898501 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI017898501 | ||
| 003 | DE-627 | ||
| 005 | 20230429081900.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200517s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.02.19.954651 |2 doi | |
| 035 | |a (DE-627)XBI017898501 | ||
| 035 | |a (biorXiv)10.1101/2020.02.19.954651 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dumitrescu, Logan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Genetic Variants and Functional Pathways Associated with Resilience to Alzheimer’s Disease |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Approximately 30% of older adults exhibit the neuropathologic features of Alzheimer’s disease (AD) without signs of cognitive impairment. Yet, little is known about the genetic factors that allow these potentially resilient individuals to remain cognitively normal in the face of substantial neuropathology. We performed a large, genome-wide association study (GWAS) of two previously validated metrics of cognitive resilience quantified using a latent variable modeling approach and representing better-than-predicted cognitive performance for a given level of neuropathology. Data were harmonized across 5,108 participants from a clinical trial of AD and three longitudinal cohort studies of cognitive aging. All analyses were run across all participants and repeated restricting the sample to individuals with normal cognition to identify variants at the earliest stages of disease. As expected, all resilience metrics were genetically correlated with cognitive performance and education attainment traits (p-values<2.5×10−20), and we observed novel correlations with neuropsychiatric conditions (p-values<7.9×10−4). Notably, neither resilience metric was genetically correlated with clinical AD (p-values>0.42) nor associated withAPOE(p-values>0.13). In single variant analyses, we observed a genome-wide significant locus among participants with normal cognition on chromosome 18 upstream ofATP8B1(index SNP rs2571244, MAF=0.08, p=2.3×10−8). The top variant at this locus (rs2571244) was significantly associated with methylation in prefrontal cortex tissue at multiple CpG sites, including one just upstream ofATPB81(cg19596477; p=2×10−13). Overall, this comprehensive genetic analysis of resilience implicates a putative role of vascular risk, metabolism, and mental health in protection from the cognitive consequences of neuropathology, while also providing evidence for a novel resilience gene along the bile acid metabolism pathway.Furthermore, the genetic architecture of resilience appears to be distinct from that of clinical AD, suggesting that a shift in focus to molecular contributors to resilience may identify novel pathways for therapeutic targets. | ||
| 650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
| 650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
| 700 | 1 | |a Mahoney, Emily R. |e verfasserin |4 aut | |
| 700 | 1 | |a Mukherjee, Shubhabrata |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Michael L. |e verfasserin |4 aut | |
| 700 | 1 | |a Bush, William S. |e verfasserin |4 aut | |
| 700 | 1 | |a Engelman, Corinne D. |e verfasserin |4 aut | |
| 700 | 1 | |a Lu, Qiongshi |e verfasserin |4 aut | |
| 700 | 1 | |a Fardo, David W. |e verfasserin |4 aut | |
| 700 | 1 | |a Trittschuh, Emily H. |e verfasserin |4 aut | |
| 700 | 1 | |a Mez, Jesse |e verfasserin |4 aut | |
| 700 | 1 | |a Kaczorowski, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Saucedo, Hector Hernandez |e verfasserin |4 aut | |
| 700 | 1 | |a Widaman, Keith F. |e verfasserin |4 aut | |
| 700 | 1 | |a Buckley, Rachel |e verfasserin |4 aut | |
| 700 | 1 | |a Properzi, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Mormino, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Yang, Hyun-Sik |e verfasserin |4 aut | |
| 700 | 1 | |a Harrison, Tessa |e verfasserin |4 aut | |
| 700 | 1 | |a Hedden, Trey |e verfasserin |4 aut | |
| 700 | 1 | |a Nho, Kwangsik |e verfasserin |4 aut | |
| 700 | 1 | |a Andrews, Shea J. |e verfasserin |4 aut | |
| 700 | 1 | |a Tommet, Doug |e verfasserin |4 aut | |
| 700 | 1 | |a Hadad, Niran |e verfasserin |4 aut | |
| 700 | 1 | |a Sanders, R. Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Ruderfer, Douglas M. |e verfasserin |4 aut | |
| 700 | 1 | |a Gifford, Katherine A. |e verfasserin |4 aut | |
| 700 | 1 | |a Moore, Annah M. |e verfasserin |4 aut | |
| 700 | 1 | |a Cambronero, Francis |e verfasserin |4 aut | |
| 700 | 1 | |a Zhong, Xiaoyuan |e verfasserin |4 aut | |
| 700 | 1 | |a Raghavan, Neha S. |e verfasserin |4 aut | |
| 700 | 1 | |a Vardarajan, Badri |e verfasserin |4 aut | |
| 700 | 1 | |a Pericak-Vance, Margaret A. |e verfasserin |4 aut | |
| 700 | 1 | |a Farrer, Lindsay A. |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Li-San |e verfasserin |4 aut | |
| 700 | 1 | |a Cruchaga, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Schellenberg, Gerard |e verfasserin |4 aut | |
| 700 | 1 | |a Cox, Nancy J. |e verfasserin |4 aut | |
| 700 | 1 | |a Haines, Jonathan L. |e verfasserin |4 aut | |
| 700 | 1 | |a Keene, C. Dirk |e verfasserin |4 aut | |
| 700 | 1 | |a Saykin, Andrew J. |e verfasserin |4 aut | |
| 700 | 1 | |a Larson, Eric B. |e verfasserin |4 aut | |
| 700 | 1 | |a Sperling, Reisa A. |e verfasserin |4 aut | |
| 700 | 1 | |a Mayeux, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Bennett, David A. |e verfasserin |4 aut | |
| 700 | 1 | |a Schneider, Julie A. |e verfasserin |4 aut | |
| 700 | 1 | |a Crane, Paul K. |e verfasserin |4 aut | |
| 700 | 1 | |a Jefferson, Angela L. |e verfasserin |4 aut | |
| 700 | 1 | |a Hohman, Timothy J. |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2022) vom: 16. Okt. |
| 773 | 1 | 8 | |g year:2022 |g day:16 |g month:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1093/brain/awaa209 |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.02.19.954651 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2022 |b 16 |c 10 | ||